Indaptus Therapeutics, Inc. (INDP) Stock Forecast
INDP analyst forecast
as of October 18, 2026- Analyst consensus
- —
- Price target
- $10.00 average of analyst targets
- Upside to target
- +280.2% from the latest close
- Next earnings
- November 11, 2026
- 52-week range
- $0.94 – $4.75
INDP price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
INDP earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current fiscal year (2026) | −$6.43 | −$6.43 | −$6.43 | −$21.58 | +70.2% | 1 |
| Next fiscal year (2027) | −$4.48 | −$4.48 | −$4.48 | −$6.43 | +30.3% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
INDP revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current fiscal year (2026) | $0 | $0 | $0 | 0.0% | — |
| Next fiscal year (2027) | $0 | $0 | $0 | 0.0% | 1 |
INDP EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
INDP EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current fiscal year (2026) | −$13.90 | −$13.90 | −$13.90 | −$13.90 | −$6.43 | −53.7% | 0 up · 1 down |
| Next fiscal year (2027) | −$12.75 | −$12.75 | −$12.75 | −$12.75 | −$4.48 | −64.9% | 0 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
INDP earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; INDP beat in 9 of 11.
What analysts expect from INDP
The average price target is $10.00, 280.2% above the latest close of $2.63. Analysts expect earnings of −$6.43 per share for 2026, +70.2% from a year earlier. For 2027 the average estimate is −$4.48 per share. Indaptus Therapeutics beat the EPS estimate in 9 of the last 11 quarters.
Related: INDP income statement, INDP key metrics, INDP chart. See the INDP stock overview for the latest quote and news.
INDP forecast FAQ
What is Indaptus Therapeutics's price target?
The average analyst price target for Indaptus Therapeutics is $10.00, 280.2% above the latest close of $2.63.
What is Indaptus Therapeutics's EPS forecast?
Analysts forecast −$6.43 per share for 2026 (range −$6.43 to −$6.43); for 2027 the estimate is −$4.48.
When does Indaptus Therapeutics report earnings?
Indaptus Therapeutics is expected to report results for the quarter ending September 30, 2026 on November 11, 2026.
Does Indaptus Therapeutics usually beat earnings estimates?
Indaptus Therapeutics reported EPS at or above the analyst estimate in 9 of the last 11 quarters.